论文部分内容阅读
随着抗肿瘤药物的研发和抗肿瘤技术的不断进步,带瘤生存的患者越来越多。带瘤生存患者的康复及生存质量也日益受到关注。为此201 3年美国国家综合癌症网络(NCCN)首次发布了针对癌症患者的生存指南。该《指南》将生存期定义为包括肿瘤被诊断后的任何时间。虽然医学不断发展和进步,但由于肿瘤发病的复杂性和目前治疗的局限性,大多肿瘤患者在疾病发展和治疗过程中仍遭
With the development of anti-tumor drugs and the progress of anti-tumor technology, there are more and more patients with tumor survival. The patients with tumor survival and quality of life are also receiving increasing attention. To this end, the National Comprehensive Cancer Network (NCCN) for the first time in 2013 has released guidelines on the survival of cancer patients. The Guide defines survival as including any time after the tumor has been diagnosed. Although the continuous development and progress of medicine, but due to the complexity of the incidence of cancer and the current limitations of treatment, most patients with cancer in the development and treatment of the disease was